HFCAS OpenIR

浏览/检索结果: 共6条,第1-6条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Progress of radiation oncology: known and unknown 期刊论文
CHINESE MEDICAL JOURNAL, 2014, 卷号: 127
-
收藏  |  浏览/下载:30/0  |  提交时间:2020/10/26
CELL LUNG-CANCER  POSITRON-EMISSION-TOMOGRAPHY  ELECTIVE NODAL IRRADIATION  HIGH-GRADE GLIOMAS  EARLY-STAGE  CONCURRENT CHEMOTHERAPY  ADJUVANT TEMOZOLOMIDE  ESOPHAGEAL CANCER  PROSTATE-CANCER  DOSE-ESCALATION  individualized medicine  radiotherapy  positron-emission tomography  targeted molecular therapy  
Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: five-year experience of a single-institution 期刊论文
CHINESE MEDICAL JOURNAL, 2011, 卷号: 124
作者:  Zhang Ye;  Xiao Jianping;  Zhang Hongzhi;  Yin Weibo;  Hu Yimin;  Song Yixin;  Zhang Ke;  Liao Zhongxing;  Li Yexiong
收藏  |  浏览/下载:34/0  |  提交时间:2020/10/26
RADIOTHERAPY  TUMORS  hypo-fractionated  stereotactic body radiation therapy  lung  metastases  prognosis  
Assessment of multimodality therapy for thymoma 期刊论文
CHINESE MEDICAL JOURNAL, 2010, 卷号: 123
作者:  Chen Jie;  Wang Ping
收藏  |  浏览/下载:262/0  |  提交时间:2020/12/28
ADJUVANT RADIATION-THERAPY  STAGE-II THYMOMA  MYASTHENIA-GRAVIS  MALIGNANT THYMOMA  RADIOTHERAPY  MANAGEMENT  RESECTION  thymus neoplasms  mediastinum neoplasms  radiotherapy  prognosis  
Advances of radiation oncology in China 期刊论文
CHINESE MEDICAL JOURNAL, 2009, 卷号: 122
-
收藏  |  浏览/下载:21/0  |  提交时间:2020/10/26
RESIDUAL PRIMARY LESION  CELL LUNG-CANCER  NASOPHARYNGEAL CARCINOMA  RADIOTHERAPY  MANAGEMENT  TRIAL  advance  radiation oncology  China  
Basic research of the relationship between irradiation dose and volume in radiation-induced pulmonary injury 期刊论文
CHINESE MEDICAL JOURNAL, 2009, 卷号: 122
-
收藏  |  浏览/下载:24/0  |  提交时间:2020/10/26
LUNG-CANCER  CONFORMAL RADIOTHERAPY  HISTOGRAM ANALYSIS  PNEUMONITIS  THERAPY  radiation-induced pulmonary injury  dose  volume  
Breast cancer radiotherapy: controversies and prospectives 期刊论文
CHINESE MEDICAL JOURNAL, 2008, 卷号: 121
-
收藏  |  浏览/下载:29/0  |  提交时间:2020/10/26
LOCAL-REGIONAL RECURRENCE  RANDOMIZED-TRIALS  NEOADJUVANT CHEMOTHERAPY  RADIATION-THERAPY  15-YEAR SURVIVAL  MASTECTOMY  IRRADIATION  CONSENSUS  ONCOLOGY